Dietary Supplement for Myopia Control
- Sponsor
- The Hong Kong Polytechnic University
- Study ID
- NCT07406906
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Myopia
Eligibility Criteria
- Sex
- ALL
- Age
- 8 Years - 13 Years
- Healthy Volunteers
- Not accepted
Interventions
- Oral dietary supplement provided in a capsule format (3 active capsules/ per day) — DIETARY_SUPPLEMENTThe active intervention in this study is an oral dietary supplement provided in a capsule format. The active ingredients include DHA/EPA and Astaxanthin.
- Oral dietary supplement provided in a capsule format (1 active capsule and 2 placebo capsules/per day) — DIETARY_SUPPLEMENTThe active intervention in this study is an oral dietary supplement provided in a capsule format. The active ingredients include DHA/EPA and Astaxanthin.
- Placebo control (3 placebo capsules/per day) — OTHER3 placebo capsules/per day
Study Details
The purpose of this clinical trial is to investigate the changes in choroidal thickness and vasculature in myopic children following oral supplementation.
Key Dates
- First listed
- Feb 12, 2026
- Start date
- Jan 30, 2026
- Status verified
- Jan 2026
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 156 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: High concentration group3 active capsules/ per day
- Experimental: Low-concentration group1 active capsule and 2 placebo capsules/per day
- Placebo Comparator: Control group3 placebo capsules/per day
Primary Outcome Measure
Change in choroidal thickness measured by OCT [ Time Frame: Choroidal thickness will be measured every month from enrollment to the end of treatment at 3 months. ]
Central Contacts
- Xiaojie WAN, MD+852 8496 7212
- Yue WU, MD+852 5171 7556
Related Studies
- Diagnostic Innovations in Glaucoma StudyRecruiting · University of California, San Diego · La Jolla, California
- Clinical Applications of Advanced Ophthalmic ImagingRecruiting · University of Miami · Miami, Florida
- Contoura With Phorcides Compared to Wavefront Optimized LASIKRecruiting · Daniel Terveen · Bozeman, Montana
- Axial Length With Adult Onset Myopia (ALWAOM)Enrolling By Invitation · Art Optical Contact Lens, Inc. · St Louis, Missouri